| Literature DB >> 33364881 |
Yasemin Erdem1, Ilknur Altunay1, Ezgi Ozkur1, Onur Sivaz1.
Abstract
OBJECTIVES: Chronic urticaria (CU) is a common skin disease characterised by skin lesions and angioedema lasting longer than six weeks. Although many factors, such as autoimmune diseases, infections, drugs and malignities, are blamed in the etiology, no reason can be found in a significant majority of the patients. The present study aims to investigate the factors which have a role in the etiology in patients diagnosed with CU.Entities:
Keywords: Etiology; chronic; urticaria
Year: 2020 PMID: 33364881 PMCID: PMC7751234 DOI: 10.14744/SEMB.2018.98216
Source DB: PubMed Journal: Sisli Etfal Hastan Tip Bul ISSN: 1302-7123
Demographic and clinical features of patient group
| Demographic and clinical features | n(%) |
|---|---|
| Gender, n (%) | |
| Female | 33 (53.2) |
| Male | 29 (46.8) |
| Age (year) mean±SD (min-max) | 41.0±13.2 (18-74) |
| Age at disease onset (year) mean±SD (min-max) | 37.4±13.0 (7-74) |
| Disease duration (month) mean±SD (min-max) | 44.6±55.1 (1-180) |
| Angioedema | 32 (51.6) |
| Physical urticaria | 25 (40.3) |
| Accompanying autoimmune disease | 14 (22.6) |
| Autoimmune tyroid disease | 12 (19.3) |
| Vitiligo | 2 (3.2) |
| Sjogren’s syndrome | 1 (1.6) |
| Accompanying infection | 15 (24.2) |
| Urinary system infection | 6 (9.6) |
| Upper tract infection | 5 (8) |
| Other | 4 (6.2) |
| UAS7 mean±SD (min-max) | 12.6±10.7 (0-40) |
UAS7: Urticaria activity score7; SD: Standart deviation.
Laboratory findings of patient group
| Laboratory findings | Mean±SD (min-max) |
|---|---|
| WBC µl/ml | 8.1±2.9 (3.9-20.8) |
| EO µl/ml | 0.20±0.15 (0.02-0.70) |
| EO% | 2.47±1.88 (0.1-9.1) |
| CRP (>5 mg/L) | 23 (40.4) |
| ESR (>20 mm/h) | 13 (24.1) |
| TSH mIU/L | 21.2±145.8 (0.3-1112) |
| FT4 ng/dL | 1.43±1.94 (0.62-10.4) |
| Positive antityroidperoksidase | 12/49 (24.5) |
| Positive antityroglobulin | 12/49 (245) |
| IgE mean±SD (min-max) | 243.5±330.1 (7.8-1883) |
| (>89 µg/L) | 34 (61.8) |
| Positive H.pylori antigene | 9/13(69) |